<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0019275"><a href="http://purl.obolibrary.org/obo/MONDO_0019275">MONDO:0019275</a></h3>
<p><strong>Label:</strong> other genetic epidermal disease</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018855">MONDO:0018855</a> (keratosis pilaris atrophicans), <a href="http://purl.obolibrary.org/obo/MONDO_0017411">MONDO:0017411</a> (neonatal inflammatory skin and bowel disease), <a href="http://purl.obolibrary.org/obo/MONDO_0016597">MONDO:0016597</a> (generalized pustular psoriasis), <a href="http://purl.obolibrary.org/obo/MONDO_0000136">MONDO:0000136</a> (keratosis follicularis spinulosa decalvans), <a href="http://purl.obolibrary.org/obo/MONDO_0014658">MONDO:0014658</a> (severe achondroplasia-developmental delay-acanthosis nigricans syndrome),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_308800">OMIM:308800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_498">Orphanet:498</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616482">OMIM:616482</a>, <a href="http://www.orpha.net/ORDO/Orphanet_294023">Orphanet:294023</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85165">Orphanet:85165</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616069">OMIM:616069</a>, <a href="http://www.orpha.net/ORDO/Orphanet_247353">Orphanet:247353</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2340">Orphanet:2340</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614204">OMIM:614204</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616106">OMIM:616106</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612843">OMIM:612843</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614328">OMIM:614328</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604093">OMIM:604093</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0011122">HP:0011122</a> (Abnormality of skin physiology) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000234">HP:0000234</a> (Abnormality of the head) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000234">HP:0000234</a> (Abnormality of the head) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000234">HP:0000234</a> (Abnormality of the head) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000234">HP:0000234</a> (Abnormality of the head) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000234">HP:0000234</a> (Abnormality of the head) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) 65.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001597">HP:0001597</a> (Abnormality of the nail) and <a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0011122">HP:0011122</a> (Abnormality of skin physiology) 60.11%</li>
</ul>
</body>
</html>
